- Otsuka touts new IgAN evidence as it seeks full approval for VoyxactOtsuka Pharmaceutical reported new evidence on Thursday that it thinks will help support a full approval for its monoclonal antibody Voyxact in a chronic autoimmune disease that affects the kidneys…Endpoints · 1mo ago↗ source
- STAT+: Drug companies, patient groups urge FDA to pause commissioner’s voucher programThe White House has used the program to reward companies that help its political goals.STAT · 1mo ago↗ source
- What RevMed’s pancreatic cancer drug meant for one patientWhy did a presentation on Revolution Medicines' pancreatic cancer drug get a standing ovation? Why did biotech stocks perform so badly this week? Find out on "The Readout LOUD."STAT